Characterization of Inhibitor IgG
Name . | Inhibitor Neutralization by fVIII Domains (%) . | Immunoprecipitation of fVIII Domains (IP units/mL) . | |||||||
---|---|---|---|---|---|---|---|---|---|
A2 . | C2 . | LCh . | A1 . | A2 . | B . | LCh . | C2 . | C2-150 . | |
MU | ≤5 | 15 | 94 | 0 | 12 | 0 | 480,000 | 187,700 | 19.7 |
RI | ≤5 | 26 | 70 | 0 | 781 | 0 | 7,755 | 4,937 | 5.4 |
MS | 27 | 30 | 78 | 0 | 204 | 0.2 | 18,890 | 1,667 | 5.1 |
Name . | Inhibitor Neutralization by fVIII Domains (%) . | Immunoprecipitation of fVIII Domains (IP units/mL) . | |||||||
---|---|---|---|---|---|---|---|---|---|
A2 . | C2 . | LCh . | A1 . | A2 . | B . | LCh . | C2 . | C2-150 . | |
MU | ≤5 | 15 | 94 | 0 | 12 | 0 | 480,000 | 187,700 | 19.7 |
RI | ≤5 | 26 | 70 | 0 | 781 | 0 | 7,755 | 4,937 | 5.4 |
MS | 27 | 30 | 78 | 0 | 204 | 0.2 | 18,890 | 1,667 | 5.1 |
The inhibitor neutralization results were previously reported15 and are expressed as percent of a control without inhibitor. The calculation of IP units/mL is described in Materials and Methods.
IP titers of IgGs after removal of anti-C2 antibodies.